Skip to content

Research study of time interval of varicella and mumps live vaccination in post KD IVIG

Research study of time interval of varicella and mumps live vaccination in post KD IVIG - KDV2

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000014491
Enrollment
50
Registered
2014-07-07
Start date
2014-07-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kawasaki Disease

Interventions

None listed

Sponsors

Tokyo Metropolitan Chilren's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Children who received an IVIG therapy for Kawasaki disease Children who were not affected mumps and VZV Children who have not got vaccination of mumps and VZV Two months to 5 years old. Written consent from the parents

Exclusion criteria

Exclusion criteria: Positive one or more of antibody titer of mumps or VZV on the examination at the admission. Malignancy diseases, immune deficiency disease or chromosomal abnormality. Received immunosuppressant or systemic steroid within one month to be hospitalized as Kawasaki disease. Chronic Kidney disease. Judged inappropriate for this study by the physicians.

Design outcomes

Primary

MeasureTime frame
The ratio of acquisition of immunity

Countries

Japan

Contacts

Public ContactYoshihiko Morikawa

Tokyo Metropolitan Children's Medical Center Clinical Research Support Center

yoshihiko_morikawa@tmhp.jp042-300-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026